Global Oncolytic Virus Immunotherapy Market, By Type (Vaccinia Virus, Herpes Simplex Virus, Reovirus, Adenovirus, Others), Application (Non-small Cell Lung Cancer (NSCLC), Melanoma, Breast Cancer, Pancreatic Cancer, Others), Route of Administration (Intravenous, Intratumoral, Other), End-Users (Clinic, Hospital, Cancer Research Institutes, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.